Neil was appointed as COO to SEHTA, July 2018, having previously been SEHTAs Medical Technology Advisor.
Neil has spent more than 25 years in the medical technology market, with a track record of success in driving business development and growth, via sales and marketing, domestic and international distributor management, market access, major accounts, new business integration, and change management, gained in the UK and in export within an SME and leading MedTech company environmen
As of November 2019, Neil is also a board member and director of SEHTA.
His areas of expertise cover a large range of medical applications and technologies including; Ophthalmic imaging, diagnosis and consumables, Cardiology, Oncology treatment, Care of the Elderly, Surgical visualisation and lasers, Wound care, Anaesthesia delivery and theatre monitoring, Dermatology, Colposcopy, ENT, and EEG/EMG/EP in neurology.
His approach is based on pragmatism, enabled by detailed market understanding, with the highest importance placed on the execution of consequent action plans as the key to success.
He has managed product though NICE Technology Appraisal (TA), and other market access processes.
Served as Industry Representative on the RCOphth Working Party into the safety of laser eye surgery in the UK, and as Chair of the Ophthalmic Special Interest Group at the ABHI.
A degree in Medical Biochemistry from London University has been enhanced by business management education at Ashridge and the completion of leadership courses from Harvard.